MTOR and cancer: This context-dependent requirement for mTOR is particularly striking, given that rapamycin is widely exploited in cancer research as a potential therapeutic molecule, yet here, its blockade prevents the restoration of protein synthesis and synaptic plasticity in the presence of APOE4 (Fig 5).